Imago BioSciences, Inc. Accumulated Other Comprehensive Income
Imago BioSciences, Inc. had Accumulated Other Comprehensive Income of -$816.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2022-11-09
- 2022-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$816.00K.
- 2022-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$828.00K.
- 2022-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$636.00K.
- 2021-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$43.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2022-09-30 | -$816.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$828.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$636.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$43.00K 10-Q · filed 2022-11-09 |
| 2021-09-30 | $16.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $17.00K 10-Q · filed 2021-08-19 |
| 2020-12-31 | -$3.00K 10-K · filed 2022-03-24 |